• 1
    Appleyard M.E., Smith A.D., Wilcock G.K., Esiri M.M. (1983) Decreased CSF acetylcholinesterase activity in Alzheimer’s disease. Lancet 2 452.
  • 2
    Arendt T., Bruckner M.K., Lange M., Bigl V. (1992) Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease resemble embryonic development—study of molecular forms. Neurochem. Int. 21 381396.
  • 3
    Atack J.R., Perry E.K., Bonham J.R., Perry R.H., Tomlinson B.E., Blessed G., Fairbairn A. (1983) Molecular forms of acetyl-cholinesterase in senile dementia of Alzheimer’s type, selective loss of the intermediate (10S) form. Neurosci. Lett. 40 199204.
  • 4
    Atack J.R., Perry E.K., Bonham J.R., Candy J.M., Perry R.H. (1986) Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47 263277.
  • 5
    Atack J.R., Perry E.K., Bonham J.R., Perry R.H. (1987) Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid. J. Neurochem. 48 18451850.
  • 6
    Atack J.R., May C., Kaye J.A., Kay A.D., Rapoport S.I. (1988) Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Ann. Neurol. 23 161167.
  • 7
    Blass J.P., Blennow K., Delacourte A., Frisoni G.B., Jefferies W.A., McRae A., Wisniewski H.M., Parshad R., Scinto L.F.M., Scheltens P., Riekkinen P.J., Swanwick G.R.J., Wahlund L., Trojanowski J.Q., Winblad B., Ihara Y. , et al. (1998) Consensus report of the Working Group on: “molecular and biochemical markers of Alzheimer’s disease.” Neurobiol. Aging 19 109116.
  • 8
    Davies C.A., Mann D.M.A., Sumpter P.Q., Yates P.O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J. Neurol. Sci. 78 151164.
  • 9
    Eckenstein F. & Sofroniew M.V. (1983) Identification of central cholinergic neurons containing both choline acetyltransferase and acetylcholinesterase and of central neurons containing only acetylcholinesterase. J. Neurosci. 3 22862291.
  • 10
    Elgavish S. & Shaanan B. (1997) Lectin-carbohydrate interactions: different folds, common recognition principles. Trends Biochem. Sci. 22 462467.
  • 11
    Fishman E.B., Siek G.C., MacCallum R.D., Bird E.D., Volicer L., Marquis J.K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain, alterations in dementia of the Alzheimer type. Ann. Neurol. 19 246252.
  • 12
    Friede R.L. (1965) Enzyme histochemical studies of senile plaques. J. Neuropathol. Exp. Neurol. 24 477491.
  • 13
    Geula C. & Mesulam M. -M. (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer’s disease. Brain Res. 498 185189.
  • 14
    Grassi J., Vigny M., Massoulié J. (1982) Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character. J. Neurochem. 38 457469.
  • 15
    Guillozet A.L., Smiley J., Mash D.C., Mesulam M. -M. (1997) Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42 909918.
  • 16
    Hammond P., Rao R., Koenigsberger C., Brimijoin S. (1994) Regional variation in expression of acetylcholinesterase mRNA in adult rat brain analyzed by in situ hybridization. Proc. Natl. Acad. Sci. USA 91 1093310937.
  • 17
    Inestrosa N.C., Alvarez A., Perez C.A., Moreno R.D., Vincente M., Linker C., Casanueva O.I., Soto C., Garrido J. (1996a) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils—possible role of the peripheral sites of the enzyme. Neuron 16 881891.
  • 18
    Inestrosa N.C., Alvarez A., Calderon F. (1996b) Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer’s filaments. Mol. Psychiatry 1 359361.
  • 19
    Kang J., Lemaire H., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K., Multhaup G., Beyreuther K., Müller-Hill B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 733736.
  • 20
    Kaufer D., Friedman A., Seidman S., Soreq H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393 373377.
  • 21
    Koelle G.B. & Friendenwald J.S. (1949) A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. Med. 70 617622.
  • 22
    Landwehrmeyer B., Probst A., Palacios J.M., Mengod G. (1993) Expression of acetylcholinesterase messenger RNA in human brain: an in situ hybridization study. Neuroscience 57 615634.
  • 23
    Liao J., Heider H., Sun M., Brodbeck U. (1992) Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes. J. Neurochem. 58 12301238.
  • 24
    Lis H. & Sharon N. (1986) Lectins as molecules and as tools. Annu. Rev. Biochem. 55 3567.
  • 25
    Luo Z., Fuentes M., Taylor P. (1994) Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes. J. Biol. Chem. 269 2721627223.
  • 26
    Mann D.M.A., Iwatsubo T., Snowden J.S. (1996) Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer’s disease: an immunohistochemical study using end-specific Aβ monoclonal antibodies. Acta Neuropathol. (Berl.) 91 647653.
  • 27
    Massoulié J. & Bon S. (1982) The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu. Rev. Neurosci. 5 57106.
  • 28
    Massoulié J., Pezzementi L., Bon S., Krejci E., Vallette F. -M. (1993) Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41 3191.
  • 29
    Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer’s disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82 42454249.
  • 30
    Méflah K., Bernard S., Massoulié J. (1984) Interactions with lectins indicate differences in the carbohydrate composition of the membrane-bound enzymes acetylcholinesterase and 5′-nucleotidase in different cell types. Biochimie 66 5969.
  • 31
    Mesulam M., Geula C., Morán M.A. (1987) Anatomy of cholinesterase inhibition of Alzheimer’s disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 22 683691.
  • 32
    Mesulam M., Geula C., Cosgrove R., Mash D., Brimijoin S. (1991) Immunohistochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral cortex. Brain Res. 539 233238.
  • 33
    Michaelson S. & Small D.H. (1993) A protease is recovered with a dimeric form of acetylcholinesterase in fetal bovine serum. Brain Res. 611 7580.
  • 34
    Mirra S.S., Gearing M., McKeel D.W.J, Crain B.J., Hughes J.P., Vanbelle G., Heyman A., Ball M.J., Clark A.W., Hansen L.A., Hedreen J.C., Joachim C.L., Kim R.C., Kirkpatrick J.B., Markesbery W.R., David D., Martínez A.J., Miller C.A., Moossy J., Morris J., Nochlin D., Perl D.P., Purohit D., Petito C.K., Rao G.R. , et al. (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer’s disease: a study of the Consortium to Establish a Registry of Alzheimer’s Disease. J. Neuropathol. Exp. Neurol. 53 303315.
  • 35
    Moral-Naranjo M.T., Cabezas-Herrera J., Vidal C.J. (1996) Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. J. Neurosci. Res. 43 224234.DOI: 10.1002/(SICI)1097-4547(19960115)43:2<224::AID-JNR10>3.0.CO;2-6
  • 36
    Morán M.A., Mufson E.J., Gómez-Ramos P. (1993) Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer’s brains. Acta Neuropathol. (Berl.).85 362369.
  • 37
    Motter R., Vigo-Pelfrey C., Kholodenko D., Barbour R., Johnson-Wood K., Galasko D., Chang L., Miller B., Clark C., Green R., Olson D., Southwick P., Wolfert R., Munroe B., Lieberburg I., Seubert P., Schenk D. (1995) Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease. Ann. Neurol. 38 643648.
  • 38
    Navaratnam D.S., Priddle J.D., McDonald B., Esiri M.M., Robinson J.R., Smith A.D. (1991) Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer’s disease. Lancet 337 447450.
  • 39
    Pfeffer R.I., Afifi A.A., Chance J.M. (1987) Prevalence of Alzheimer’s disease in a retirement community. Am. J. Epidemiol. 125 420436.
  • 40
    Probst A., Langui D., Ulrich J. (1991) Alzheimer’s disease: a description of the structural lesions. Brain Pathol. 1 229239.
  • 41
    Sáez-Valero J., Tornel P.L., Muñoz-Delgado E., Vidal C.J. (1993) Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain. J. Neurosci. Res. 35 678689.
  • 42
    Sáez-Valero J., Sberna G., McLean C., Masters C.L., Small D.H. (1997) Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer’s disease. Lancet 350 929.
  • 43
    Saxena A., Raveh L., Ashani Y., Doctor B.P. (1997) Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase. Biochemistry 36 74817489.
  • 44
    Saxena A., Ashani Y., Raveh L., Stevenson D., Patel T., Doctor B.P. (1998) Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. Mol. Pharmacol. 53 112122.
  • 45
    Sberna G., Sáez-Valero J., Beyreuther K., Masters C.L., Small D.H. (1997) The amyloid β-protein of Alzheimer’s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69 11771184.
  • 46
    Sberna G., Sáez-Valero J., Li Q., Czech C., Beyreuther K., Masters C.L., McLean C.A., Small D.H. (1998) Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer’s disease. J. Neurochem. 71 723731.
  • 47
    Schegg K.M., Harrington L.S., Neilsen S., Zweig R.M., Peacock J.H. (1992) Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer’s disease. Neurobiol. Aging 13 697704.
  • 48
    Schoenberg B.S., Kokmen E., Okazaki H. (1987) Alzheimer’s disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann. Neurol. 22 724729.
  • 49
    Seidman S., Sternfeld M.B, Timberg R., Kaufernachum D., Soreq H. (1995) Synaptic and epidermal accumulation of human acetylcholinesterase is encoded by alternative 3′-terminal exons. Mol. Cell. Biol. 15 29933002.
  • 50
    Shen Z. -X. (1997) An CSF anomalous molecular form of acetylcholinesterase in demented and non-demented subject. Neuroreport 8 32293232.
  • 51
    Shen Z. & Zhang Z. (1993) Anomalous acetylcholinesterase in CSF without clinical diagnosis of Alzheimer’s disease. Lancet 342 62.
  • 52
    Siek G.C., Katz L.S., Fishman E.B., Korosi T.S., Marquis J.K. (1990) Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain. Biol. Psychiatry 27 573580.
  • 53
    Silman I., Lyles J.M., Barnard E.A. (1978) Intrinsic forms of acetylcholinesterase in skeletal muscle. FEBS Lett. 94 166170.
  • 54
    Small D.H., Michaelson S., Sberna G. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer’s disease. Neurochem. Int. 28 453483.
  • 55
    Smith A.D., Jobst K.A., Navaratnam D.S., Shen Z., Priddle J.D., McDonald B., King E., Esiri M.M. (1991) Anomalous acetylcholinesterase in lumbar CSF in Alzheimer’s disease. Lancet 338 1538.
  • 56
    Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 7685.
  • 57
    Soreq H., Ben-Aziz R., Prody C.A., Seidman S., Gnatt A., Neville L., Lieman-Hurwitz J., Lev-Lehman E., Ginzberg D., Lapidot-Lifson Y., Zakut H. (1990) Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G+C-rich attenuating structure. Proc. Natl. Acad. Sci. USA 87 96889692.
  • 58
    Treskatis S., Ebert C., Layer P.G. (1992) Butyrylcholinesterase from chicken brain is smaller than that from serum: its purification, glycosylation, and membrane association. J. Neurochem. 58 22362247.
  • 59
    Turner G.A. (1992) N-Glycosylation of serum proteins in disease and its investigation using lectins. Clin. Chim. Acta 208 149171.
  • 60
    Ulrich J., Meier-Ruge W., Probst A., Meier E., Ipsen S. (1990) Senile plaques, staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol. (Berl.) 80 624628.
  • 61
    Vidal C.J. (1996) Glycosylation of cholinesterases and its alteration in some pathological states. Recent Res. Dev. Neurochem. 1 3754.
  • 62
    Wright C.I., Geula C., Mesulam M. -M. (1993) Neuroglial cholinesterases in the normal brain and in Alzheimer’s disease: relationship to plaques, tangles and patterns of selective vulnerability. Ann. Neurol. 34 373384.
  • 63
    Younkin S.G., Goodridge B., Katz J., Lockett G., Nafziger D., Usiak M.F., Younkin L.H. (1986) Molecular forms of acetylcholinesterase in Alzheimer’s disease. Fed. Proc. 45 29822988.